Patents Assigned to SHIFTBIO
  • Exosome-based anticancer agent
    Patent number: 11952412
    Abstract: The present invention provides a recombinant exosome and uses thereof. More particularly, the present invention provides a recombinant exosome wherein a phagocytosis promoting protein is presented on the surface of the exosome.
    Type: Grant
    Filed: April 3, 2022
    Date of Patent: April 9, 2024
    Assignee: SHIFTBIO
    Inventors: Eun-ee Koh, Eun Jung Lee, Yoo Soo Yang, In-San Kim